Malaysia Pharmas Maneuver For Global Role In Generics, Clinical Research
This article was originally published in PharmAsia News
Executive Summary
Malaysia’s pharmaceutical industry has been maneuvering quietly in the past few years to play a larger role in what is expected to be a $1.1 trillion global drug market by 2015.
Malaysia’s pharmaceutical industry has been maneuvering quietly in the past few years to play a larger role in what is expected to be a $1.1 trillion global drug market by 2015. To that end, Malaysia’s Economic Transformation Program has encouraged production of generic drugs for export as well as a local platform for clinical research. The task is considered formidable for a country lagging behind neighboring nations such as China, Singapore and South Korea. Instead of trying to compete with China and India in generics and outsourcing, the head of the Pharmaceutical Association of Malaysia said the nation should develop its own unique competitive edge by focusing on fellow ASEAN countries and the Middle East. (Click here for more
)
“Malaysia Wises Up To Pharmaceutical Allure” – The Edge (Malaysia) (4/9/12)